Actively Recruiting
Elbow Hemiarthroplasty Versus ORIF for Distal Humeral Fractures
Led by Herlev and Gentofte Hospital · Updated on 2023-10-06
44
Participants Needed
1
Research Sites
673 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized control trial comparing the outcome of ORIF (open reduction and internal fixation) with EHA (elbow hemiarthroplasty) for distal humeral fractures in patients aged 50 years or above.
CONDITIONS
Official Title
Elbow Hemiarthroplasty Versus ORIF for Distal Humeral Fractures
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Distal humeral fracture AO/OTA type C2 or C3 confirmed by plain radiographs and CT scan
- ASA score 1 to 3 and physically fit for surgery
- Age 50 years or older
You will not qualify if you...
- Unable to follow rehabilitation or answer questionnaires due to physical or cognitive issues
- Significant elbow osteoarthritis based on radiographs and CT scan
- Fracture older than 6 weeks
- Other associated elbow fractures
- Pathological fractures or relevant elbow pathology
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Herlev and Gentofte University Hospital
Copenhagen, Denmark
Actively Recruiting
Research Team
A
Ali Al-Hamdani, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here